Background
Rootines, developed by ASD.ai LLC, is a patient engagement platform designed to support individuals with pediatric complex chronic conditions. Established in 2020 and headquartered in Red Oak, Texas, Rootines aims to enhance the well-being of neurodiverse individuals by providing tools for caregivers and healthcare professionals to monitor and manage daily routines effectively. The platform's mission is to improve patient outcomes through continuous data collection and analysis, facilitating early intervention and personalized care plans.
Key Strategic Focus
Rootines specializes in developing mobile applications and web portals that enable caregivers to track various aspects of an individual's daily routine, including mood, medication adherence, sleep patterns, and hydration. By leveraging artificial intelligence and machine learning, the platform identifies insights that might otherwise be missed, thereby enhancing patient engagement and care. The primary markets targeted include hospitals, therapy centers, and healthcare clinics, with a focus on conditions such as Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), bipolar disorder, and other mental health disorders.
Financials and Funding
In September 2021, ASD.ai secured a $1 million angel investment from Determined Capital LLC, founded by Tim Davis. This funding was allocated for key hires and further product development, including the completion of a web portal to support business-to-business applications and commercial users such as therapists' offices and hospitals. Prior to this investment, ASD.ai was a recipient of a Microsoft for Startups grant.
Pipeline Development
Rootines has expanded its platform to include support for various conditions:
- Autism Spectrum Disorder (ASD): The initial focus of the platform, providing tools for caregivers to monitor and manage daily routines.
- Mental Health: In July 2022, Rootines added mental health tracking capabilities, allowing users to monitor mood, sleep, diet, and other factors affecting mental well-being.
- Neonatal Intensive Care Unit (NICU) Follow-Up: Announced in August 2022, this solution enables tracking of feeding, weight, oxygen therapy, and medication for infants discharged from the NICU, as well as monitoring parental stress to provide additional support.
Technological Platform and Innovation
Rootines distinguishes itself through its integration of artificial intelligence and machine learning to analyze patient-reported outcomes and remote patient monitoring data. The platform's proprietary technologies include:
- Data Collection and Analysis: Utilizing AI and machine learning algorithms to identify patterns and insights from daily routine data.
- Remote Patient Monitoring: Integrating with smart devices to collect real-time health data, such as weight and sleep quality.
- EMR/EHR Integration: Offering seamless integration with electronic medical records to streamline data sharing and enhance clinical workflows.
Leadership Team
The executive team at ASD.ai comprises:
- Tamera Jackson (TJ), CEO: Co-founder and Chief Executive Officer, leading the company's strategic vision and operations.
- Blake Rutherford, CMO: Co-founder and Chief Medical Officer, overseeing medical strategy and product development.
- Dominic Foster, CTO: Co-founder and Chief Technology Officer, responsible for technological innovation and infrastructure.
- Jerome Pascua, Senior VP of Software: Leading software development and design initiatives.
Competitor Profile
Market Insights and Dynamics
The market for patient engagement platforms, particularly those focusing on pediatric complex chronic conditions, is experiencing significant growth. Factors contributing to this expansion include increased awareness of neurodiverse conditions, the need for continuous monitoring, and the integration of technology in healthcare to improve patient outcomes.
Competitor Analysis
Rootines operates in a competitive landscape with several notable companies:
- Zocdoc: A venture capital-backed company based in New York, NY, offering a platform for booking medical appointments.
- Thorne: Provides at-home biomarker tests and digestive enzyme supplements, focusing on personalized health solutions.
- Vous Vitamin: Offers personalized vitamins and situational supplements tailored to individual needs.
- D'Adamo Personalized Nutrition: Provides nutritional support based on blood type and genotype diets.
- Vitagene: Delivers personalized health and wellness plans, including diet, fitness, and supplementation recommendations.
Strategic Collaborations and Partnerships
ASD.ai has engaged in strategic collaborations to enhance its market position and innovation capacity:
- Microsoft for Startups Grant: Received a grant to support product development and technological advancements.
- Determined Capital LLC: Secured a $1 million investment to advance product development and expand business-to-business applications.
Operational Insights
Rootines differentiates itself through its focus on pediatric complex chronic conditions and the integration of AI and machine learning to provide actionable insights. The platform's ability to connect caregivers, patients, and healthcare professionals through continuous data collection and analysis offers a competitive advantage in enhancing patient engagement and outcomes.
Strategic Opportunities and Future Directions
Rootines is positioned to capitalize on the growing demand for patient engagement solutions in pediatric healthcare. Future directions include expanding support for additional conditions, enhancing integration with healthcare systems, and leveraging data analytics to provide more personalized care plans. By building on its current strengths and strategic partnerships, Rootines aims to become a leader in the patient engagement platform market for pediatric complex chronic conditions.
Contact Information
- Website: www.rootines.app
- Email: sales@rootines.app
- Headquarters: Red Oak, Texas, United States
